08/04/2020
https://congress.gov...
"This is according to the CBO, and they confirmed that there would be a loss of cures available on the market."
"Policies that incentivize investment in pharmaceutical innovation is a good thing, and that is where we need to be focused."
"We just simply cannot go down that path of eliminating any potential cure for some of these serious diseases."
"I do wish that my friends on the other side of the aisle, if they were serious about true reform and lowering prices we would be looking at something like H.R. 19 instead of pushing something like H.R..."